SureTrader
Home > Boards > US Listed > Cannabis > Zynerba Pharmaceuticals (ZYNE)

This stock was down in value for so

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
LittleBird Member Profile
 
Followed By 0
Posts 18
Boards Moderated 0
Alias Born 09/29/17
160x600 placeholder
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/14/2018 4:57:38 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/14/2018 2:56:28 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/13/2018 3:52:26 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/12/2018 9:10:20 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/9/2018 1:17:29 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 2/1/2018 9:41:44 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/30/2018 9:01:37 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/16/2018 4:13:39 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/16/2018 4:13:14 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/16/2018 4:13:14 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/16/2018 4:12:45 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/16/2018 4:12:18 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/4/2018 4:09:09 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/4/2018 4:08:17 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/4/2018 8:01:55 AM
Zynerba Pharmaceuticals Provides 2018 Clinical and Corporate Update GlobeNewswire Inc. - 1/3/2018 4:30:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/3/2018 6:06:33 AM
Biotech Market Banking on Big Cannabis Returns NetworkNewsWire - 12/19/2017 8:45:00 AM
Dangerous Opioid Side Effects Shift Market Focus to Cannabis for Chronic Pain NetworkNewsWire - 12/13/2017 8:45:00 AM
Advanced Biosynthesis Setting New Standards for Cannabinoid-based Pain Management NetworkNewsWire - 12/6/2017 8:45:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/4/2017 7:31:33 AM
Zynerba Pharmaceuticals Announces New ZYN002 Data from STAR 1 and STAR 2 Studies in Patients with Focal Seizures at the 2017 ... GlobeNewswire Inc. - 12/3/2017 12:01:00 PM
Zynerba Pharmaceuticals Announces Poster Presentation at the 2017 Annual Meeting of the American Epilepsy Society (AES) GlobeNewswire Inc. - 11/21/2017 9:00:00 AM
Innovation Drives Value for Leading Cannabis Biotechs NetworkNewsWire - 11/15/2017 8:45:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/14/2017 8:03:15 AM
LittleBird   Friday, 10/06/17 11:44:06 AM
Re: None
Post # of 1048 
This stock was down in value for so long - I think shakeouts are bound to happen for various reasons:

Shorts are slowly, slowly being squeezed out. It fell a long way on the bad news - that's a lot of range for shorting that is being sorted out now.

People who are tired of the stress are getting out with minimized or reversed losses. These buyers are being replaced, but it's eating up some of the momentum.

------

I would also like to see another piece of good news from ZYNE as just one current catalyst for revaluation is having a hard time driving growth in the face of the two failures.

Long term prospects for ZYNE are gold though. If we get a good December update and success from either of the THC patch trials there isn't much left to hold ZYNE back. That's when a pre-commercialization value of $25 is realistic, I think.

In the meantime, fingers crossed for a reasonable climb to the $12's by end of next week.



Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist